14.05.2014
- A day after U.S. drugmaker Allergan rejected its initial takeover approach, Canada's Valeant Pharmaceuticals International said it would "improve" the unsolicited $47 billion offer...
13.05.2014
- U.S. drugmaker Allergan has rejected the $47 billion takeover bid of Canada-based Valeant Pharmaceuticals International, saying the suitor's proposed cost cuts of at least $2.7...
24.04.2014
- Canada's Valeant Pharmaceuticals International and activist investor Bill Ackman have made an unsolicited $47 billion bid to buy Botox maker Allergan in a move to create one of the...
07.05.2013
- Just two years ago, Regeneron Pharmaceuticals was a relatively obscure biotech company in the village of Tarrytown, a picturesque New York suburb better known for "Rip Van Winkle,"...
02.04.2013
- Neurological and dermatology drugs maker Merz Pharma offered to buy cosmetic products maker Obagi Medical Products for $383.5 million, topping a bid by Canada's Valeant...
15.10.2012
- The U.S. Supreme Court on Monday rejected Allergans appeal of a ruling that favored generic drugmaker Watson Pharmaceuticals over patents related to the treatment of an overactive...
27.09.2012
- The European Union said it wants tougher rules governing the safety and monitoring of medical devices after weak EU regulations were partly blamed for a global scandal over French...
06.04.2011
- Merck & Co said on Tuesday it would acquire eye treatment maker Inspire Pharmaceuticals for about $430 million to expand its ophthalmology business. Inspire's key product is...
